ChristopherConradyMDPhD

Ophthalmology • Omaha, NE

Retinal Disease, Uveitis

Surgical retina fellow

Join to view full profile

Dr. Conrady is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Conrady's full profile

Already have an account?

Office
Truhlsen Eye Institute
3902 Leavenworth St
Omaha, NE 68105

Education & Training

University of Michigan Health SystemFellowship, Surgical Retina and Vitreous, 2019
University of Utah HealthResidency, Ophthalmology, 2015 - 2018
University of Oklahoma College of MedicineClass of 2014

Certifications & Licensure

NE State Medical License 2021 - 2026
MI State Medical License 2019 - 2023
UT State Medical License 2015 - 2020
American Board of Ophthalmology Ophthalmology

Publications & Presentations

PubMed

Inflammation and Occlusive Retinal Vasculitis Post Faricimab.
Will Bruening, Sean Kim, Steven Yeh, Pukhraj Rishi, Christopher D Conrady
JAMA Ophthalmology. 2025-01-23
Clinical, molecular, and immunologic mechanisms of CMV retinitis: Evolving understanding in HIV and non-HIV immunosuppressed patients.
Helen Song, Jack Begley, Collin Asheim, Thomas A Albini, Christopher D Conrady
Expert Review of Ophthalmology. 2025-01-01
A Better Understanding of the Clinical and Pathological Changes in Viral Retinitis: Steps to Improve Visual Outcomes.
Nghi M Nguyen, Christopher D Conrady
Microorganisms. 2024-12-05

Press Mentions

Faricimab Again Linked to Rare but Severe Eye Adverse EffectsJanuary 24th, 2025
Managing Endophthalmitis After Intravitreal InjectionsDecember 1st, 2021